US 12115149
Formulations, methods, kits, and dosage forms
granted A61KA61K31/436A61K31/495
Quick answer
US patent 12115149 (Formulations, methods, kits, and dosage forms) held by MedRegen, LLC expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MedRegen, LLC
- Grant date
- Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/436, A61K31/495, A61K47/02, A61K47/10